Tag Archives: Ovarian

AstraZeneca, Merck's Lynparza plows ahead in ovarian cancer with $1B-plus approval, phase 3 data

The year may be winding down, but AstraZeneca and Merck’s Lynparza sure isn’t. It picked up a blockbuster new approval late Wednesday and followed up the act by posting positive phase 3 data Thursday morning. U.S. regulators green-lighted the fast-growing PARP inhibitor in BRCA-mutated ovarian cancer patients who’ve responded partially or completely to an initial… Read More »

Q+A about Ovarian Cancer – A Silent Killer

by Lindsey Grossman In 2018, an estimated 22,240 women will be diagnosed with ovarian cancer and about 14,070 will die from ovarian cancer. One in 78 women will get ovarian cancer in her lifetime, while 1 in 108 women will die. Ashley Case, MD, a gynecologic oncologist answers our questions about this silent killer that ranks fifth in… Read More »